🔎 Trials Near Me

Akèy › Ensifizyans kadyak › Minnesota › Minneapolis

Etid klinik pou Ensifizyans kadyak nan Minneapolis, MN

21 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Minneapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

ELEVATE-HFpEF Clinical Study

Ap rekrite
  • M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
Laj 40 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06678841

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Ap rekriteFaz 3
  • Minneapolis VA Health Care System, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06935370

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Ap rekriteFaz 3
  • Minneapolis VA Health Care System, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06424288

Alleviant ALLAY-HFrEF Study

Ap rekrite
  • Minneapolis Heart Institute Foundation, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • University of Minnesota, Minneapolis
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Ap rekriteFaz 3
  • Research Site, Minneapolis
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Ap rekriteFaz 3
  • Minneapolis, MN Investigative Site CON-10035, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Ap rekriteFaz 3
  • Minneapolis, MN Investigative Site 10091, Minneapolis
  • Minneapolis, MN Investigative Site 10035, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Ap rekrite
  • Abbott Northwestern Hospital, Minneapolis
  • University of Minnesota, Minneapolis
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Ap rekriteEtid obsèvasyon
  • Minneapolis, Minneapolis
Tout laj · Tout sèks · Mizajou Aug 20, 2026 · NCT00271180

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Ap rekriteFaz 3
  • Tenax Investigational Site, Minneapolis
Laj 18 a 85 · Tout sèks · Mizajou Aug 19, 2026 · NCT07288398

Alleviant ALLAY-HF Study

Ap rekrite
  • Minneapolis Heart Institute Foundation, Minneapolis
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

Ap rekrite
  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Laj 60 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05996328

Assessment of CCM in HF With Higher Ejection Fraction

Ap rekrite
  • Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05064709

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

Ap rekriteFaz 3
  • Minneapolis, MN Investigative Site FIN-10035, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Ap rekrite
  • University of Minnesota, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Ap rekrite
  • Minneapolis Heart Institute, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

CCM OPEN HF Registry

Ap rekriteEtid obsèvasyon
  • Minneapolis Heart Institute Research Foundation, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07112924

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

Ap rekriteEtid obsèvasyon
  • Minneapolis Heart Institute Foundation, Minneapolis
Laj 18 ak plis · Tout sèks · Mizajou Dec 23, 2025 · NCT07131631

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Ap rekriteEtid obsèvasyon
  • Minneapolis Heart Institute Foundation/ Allina Health, Minneapolis
Laj 18 a 100 · Tout sèks · Mizajou May 22, 2024 · NCT06425848

Etid Ensifizyans kadyak nan lòt vil

Lòt etid nan Minneapolis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.